William Fearon, MD
Clinical Trials
- Recruiting Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
- Not Recruiting FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
- Not Recruiting TAXUS Libertē Post Approval Study
- Not Recruiting Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
